XML 57 R37.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract] |
Schedule of Intangible Assets and Goodwill [Table Text Block] | The gross carrying amount of goodwill and other intangible assets and the related accumulated amortization for intangible assets subject to amortization and accumulated goodwill impairment charges are as follows:
| As of December 31, 2021 |  | As of December 31, 2020
(in millions) | Gross Carrying Amount |  | Accumulated Amortization/Write-offs(1) |  | Gross Carrying Amount |  | Accumulated Amortization/Write-offs
Technology-related | $ | 11,957 |  |  | $ | (6,754) |  |  | $ | 11,059 |  |  | $ | (6,179) |
Patents | 494 |  |  | (398) |  |  | 511 |  |  | (407) |
Other intangible assets | 1,900 |  |  | (1,325) |  |  | 1,775 |  |  | (1,220) |
Amortizable intangible assets | $ | 14,351 |  |  | $ | (8,476) |  |  | $ | 13,345 |  |  | $ | (7,806) |
Goodwill | $ | 21,888 |  |  | $ | (9,900) |  |  | $ | 19,924 |  |  | $ | (9,973) |
IPR&D | 126 |  |  |  |  | 257 |  |  |
Technology-related | 120 |  |  |  |  | 120 |  |  |
Indefinite-lived intangible assets | $ | 246 |  |  |  |  | $ | 377 |  |  |
(1) In the fourth quarter of 2020, we recorded goodwill impairment charges of $73 million related to the Specialty Pharmaceuticals business and classified the remaining assets and liabilities as held for sale as of December 31, 2020. On March 1, 2021, we completed the divestiture of the Specialty Pharmaceuticals business. The goodwill impairment charges of $73 million related to the Specialty Pharmaceuticals business are no longer presented within accumulated write-offs above as of December 31, 2021.
Schedule of Goodwill [Table Text Block] | The following represents our goodwill balance by global reportable segment and our separately presented Specialty Pharmaceuticals operating segment:
(in millions) | MedSurg |  | Rhythm and Neuro |  | Cardiovascular |  | Specialty Pharmaceuticals |  | Total
Balance as of December 31, 2019 | $ | 2,061 |  |  | $ | 2,192 |  |  | $ | 5,676 |  |  | $ | 247 |  |  | $ | 10,176 |
Foreign currency fluctuations and other changes | (2) |  |  | 3 |  |  | 22 |  |  | — |  |  | 22 |
Goodwill impairment charges | — |  |  | — |  |  | — |  |  | (73) |  |  | (73) |
Goodwill reclassified to Current assets held for sale | — |  |  | — |  |  | — |  |  | (175) |  |  | (175) |
Balance as of December 31, 2020 | $ | 2,059 |  |  | $ | 2,194 |  |  | $ | 5,697 |  |  | $ | — |  |  | $ | 9,951 |
Foreign currency fluctuations and other changes | (5) |  |  | (1) |  |  | (21) |  |  | — |  |  | (27) |
Goodwill acquired | 544 |  |  | 1,309 |  |  | 210 |  |  | — |  |  | 2,064 |
Balance as of December 31, 2021 | $ | 2,598 |  |  | $ | 3,503 |  |  | $ | 5,887 |  |  | $ | — |  |  | $ | 11,988 |
Schedule of Expected Amortization Expense [Table Text Block] | Estimated Amortization expense for each of the five succeeding fiscal years based upon our amortizable intangible asset portfolio as of December 31, 2021 is as follows (in millions):
Fiscal Year |
2022 | $ | 752 |
2023 | 738 |
2024 | 703 |
2025 | 644 |
2026 | 620 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267 + Details
Name: | us-gaap_ScheduleOfGoodwillTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 + Details
Name: | us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration